Maarouf A. Hoteit, MD
Associate Professor of Clinical Medicine
Director of Multidisciplinary Liver Tumor Clinic, Hospital of the University of Pennsylvania
Program Director, Transplant Hepatology Fellowship, Hospital of the University of Pennsylvania
Medical Director of Liver Transplantation, Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
Liver Transplant Program
3400 Spruce Street
2 Dulles
Philadelphia, PA 19104
Liver Transplant Program
3400 Spruce Street
2 Dulles
Philadelphia, PA 19104
Office: (215) 349-5581
Fax: 215-615-1601
Fax: 215-615-1601
Education:
BS (Biology)
American University of Beirut, 1996.
MD
American University of Beirut, 2000.
Permanent linkBS (Biology)
American University of Beirut, 1996.
MD
American University of Beirut, 2000.
Description of Clinical Expertise
Liver CancerLiver Transplantation
Description of Research Expertise
Liver CancerLiver Transplantation
Selected Publications
Parikh ND, Mehta N, Hoteit MA, Yang JD, John BV, Moon AM, Salgia RJ, Pillai A, Kassab I, Saeed N, Thyssen E, Nathani P, McKinney J, Chan W, Durkin C, Connor M, Alsudaney M, Konjeti R, Durand B, Nissen NN, Kim HP, Paknikar R, Rich NE, Schipper MJ, Singal AG.: Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma. Cancer 1;128(19): 3470-3478, Oct 2022.Perkons NR, Metz DC, Siegelman ES, Yang Z, Collingwood R, Fortuna D, Pryma DA, Abt P, Hoteit MA.: Where LI-RADS Falls Short: Two Cases of Image-diagnosed HCC, Found to Be NET on Explant. Transplantation 1;106(7):e350-e351, Jul 2022.
Mettikanont P, Kalluri A, Bittermann T, Phillips N, Loza BL, Rosen M, Siegelman E, Furth E, Abt P, Olthoff K, Shaked A, Hoteit M, Reddy KR.: The Course of LIRADS 3 and 4 Hepatic Abnormalities as Correlated With Explant Pathology: A Single Center Experience. J Clin Exp Hepatol 12(4):1048-1056, Jul-Aug 2022.
Mehta N, Frenette C, Tabrizian P, Hoteit M, Guy J, Parikh N, Ghaziani TT, Dhanasekaran R, Dodge JL, Natarajan B, Holzner ML, Frankul L, Chan W, Fobar A, Florman S, Yao FY.: Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium. Gastroenterology 161(5):1502-1512, Nov 2021.
Mezina A, Philips N, Bogus Z, Erez N, Xiao R, Fan R, Olthoff KM, Reddy KR, Samadder NJ, Nielsen SM, Hatchell KE, Esplin ED, Rustgi AK, Katona BW, Hoteit MA, Nathanson KL, Wangensteen KJ.: Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants. JCO Precis Oncol 10;5:PO.21.00079: PO, Jun 2021.
Adeniji N, Arjunan V, Prabhakar V, Mannalithara A, Ghaziani T, Ahmed A, Kwo P, Nguyen M, Melcher ML, Busuttil RW, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Burcin Taner C, Hoteit MA, Verna EC, Halazun KJ, Tevar AD, Humar A, Chapman WC, Vachharajani N, Aucejo F, Nydam TL, Markmann JF, Mobley C, Ghobrial M, Langnas AN, Carney CA, Berumen J, Schnickel GT, Sudan DL, Hong JC, Rana A, Jones CM, Fishbein TM, Agopian V, Dhanasekaran R.: Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors. Liver Transplantation 27(5): 684-698, May 2021.
Krumeich LN, Mancinelli J, Cucchiara A, Eddinger K, Aufhauser D, Goldberg DW, Siegelman ES, Rosen M, Reddy KR, Hoteit M, Furth EE, Olthoff KM, Shaked A, Levine M, Abt P.: Occult Hepatocellular Carcinoma Associated with Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients. Liver Transplantation 27(9):1248-1261, April 2021.
Kardashian A, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Taner CB, Aucejo F, Tevar AD, Humar A, Verna EC, Halazun KJ, Chapman WC, Vachharajani N, Hoteit M, Levine MH, Nguyen MH, Melcher ML, Langnas AN, Carney CA, Mobley C, Ghobrial M, Amundsen B, Markmann JF, Sudan DL, Jones CM, Berumen J, Hemming AW, Hong JC, Kim J, Zimmerman MA, Nydam TL, Rana A, Kueht ML, Fishbein TM, Markovic D, Busuttil RW, Agopian VG.: Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. Hepatology 72(6): 2014-2028, Dec 2020.
Ortega-Legaspi JM, Hoteit M, Wald J.: Immune benefit of combined heart and liver transplantation. Curr Opin Organ Transplant 25: 513-518, Oct 2020.
Hoteit MA, Wojcieszynski A, Currie B, Levine MH, Forde KA, Reiss KA, Nadolski G, Soulen MC, Helmke S, Everson GT, Ben-Josef E: Deterioration in liver function after liver-directed therapy for hepatocellular carcinoma measured by cholate clearance. GastroHep 2(5): 232-239, September 2020.